Información:
Error:
ID
29321
Descripción
Study part: Vital Signs Screening. A Phase III, Multicenter, Randomized, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection Compared With Sham In Subjects with Macular Edema Secondary To Branch Retinal Vein Occlusion.
Palabras clave
Versiones (1)
- 18/3/18 18/3/18 -
Titular de derechos de autor
Roche
Subido en
18 de marzo de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Vital Signs Screening Ranibizumab Macular Edema Secondary To Branch Retinal Vein Occlusion FVF4165g
Vital Signs Screening
- StudyEvent: ODM
Similar models
Vital Signs Screening
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Date of visit
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
vital signs
Item
Were any vital signs recorded at this visit?
boolean
C0518766 (UMLS CUI [1])
Vital Signs Date
Item
Vital Signs Date:
date
C2826644 (UMLS CUI [1])
Vital Signs Time
Item
Vital Signs Time:
time
C2826762 (UMLS CUI [1])
Temperature
Item
Temp:
float
C0005903 (UMLS CUI [1])
Temperature
Item
Temp:
float
C0005903 (UMLS CUI [1])
Pulse
Item
Pulse:
integer
C0232117 (UMLS CUI [1])
Respiratory rate
Item
Resp:
integer
C0231832 (UMLS CUI [1])
systolic blood pressure
Item
BP:
integer
C0871470 (UMLS CUI [1])
diastolic blood pressure
Item
BP:
integer
C0428883 (UMLS CUI [1])
Height
Item
Height:
integer
C0005890 (UMLS CUI [1])
Weight
Item
Weight:
float
C0005910 (UMLS CUI [1])
Sin comentarios